|1 Table of Contents 3
|1.1 List of Tables 13
|1.2 List of Figures 26
2 Introduction 27
2.1 Injectable Drug Delivery Overview 27
3 Products under Development 28
3.1 Injectable Drug Delivery – Pipeline Products by Stage of Development 28
3.2 Injectable Drug Delivery – Pipeline Products by Segment 29
3.3 Injectable Drug Delivery – Pipeline Products by Territory 30
3.4 Injectable Drug Delivery – Pipeline Products by Regulatory Path 32
3.5 Injectable Drug Delivery – Pipeline Products by Estimated Approval Date 33
3.6 Injectable Drug Delivery – Ongoing Clinical Trials 34
4 Injectable Drug Delivery – Pipeline Products under Development by Companies 35
4.1 Injectable Drug Delivery Companies – Pipeline Products by Stage of Development 35
4.2 Injectable Drug Delivery – Pipeline Products by Stage of Development 41
5 Injectable Drug Delivery Companies and Product Overview 47
5.1 AcelRx Pharmaceuticals Inc Company Overview 47
5.1.1 AcelRx Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 47
5.2 Adalvo Company Overview 49
5.2.1 Adalvo Pipeline Products & Ongoing Clinical Trials Overview 49
5.3 AdrenaCard, Inc. Company Overview 50
5.3.1 AdrenaCard, Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
5.4 AktiVax Inc. Company Overview 51
5.4.1 AktiVax Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
5.5 Alexion Pharmaceuticals Inc Company Overview 52
5.5.1 Alexion Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 52
5.6 Allergan Ltd Company Overview 53
5.6.1 Allergan Ltd Pipeline Products & Ongoing Clinical Trials Overview 53
5.7 Alsensa ApS Company Overview 54
5.7.1 Alsensa ApS Pipeline Products & Ongoing Clinical Trials Overview 54
5.8 Amneal Pharmaceuticals Inc Company Overview 55
5.8.1 Amneal Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 55
5.9 Antares Pharma Inc Company Overview 56
5.9.1 Antares Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview 56
5.10 Apellis Pharmaceuticals Inc Company Overview 64
5.10.1 Apellis Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 64
5.11 Aptissen SA Company Overview 68
5.11.1 Aptissen SA Pipeline Products & Ongoing Clinical Trials Overview 68
5.12 Aquavit Pharmaceuticals Inc Company Overview 71
5.12.1 Aquavit Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 71
5.13 Artemes Technologies, Inc. Company Overview 72
5.13.1 Artemes Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 72
5.14 Ascendis Pharma AS Company Overview 73
5.14.1 Ascendis Pharma AS Pipeline Products & Ongoing Clinical Trials Overview 73
5.15 ASCIL Biopharm Company Overview 78
5.15.1 ASCIL Biopharm Pipeline Products & Ongoing Clinical Trials Overview 78
5.16 Ash Access Technology Inc Company Overview 81
5.16.1 Ash Access Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 81
5.17 ASIS Corp Company Overview 82
5.17.1 ASIS Corp Pipeline Products & Ongoing Clinical Trials Overview 82
5.18 Auckland Bioengineering Institute Company Overview 83
5.18.1 Auckland Bioengineering Institute Pipeline Products & Ongoing Clinical Trials Overview 83
5.19 AzureBio SL Company Overview 84
5.19.1 AzureBio SL Pipeline Products & Ongoing Clinical Trials Overview 84
5.20 Becton Dickinson and Co Company Overview 85
5.20.1 Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 85
5.21 Bespak Europe Ltd Company Overview 87
5.21.1 Bespak Europe Ltd Pipeline Products & Ongoing Clinical Trials Overview 87
5.22 Biocorp Production SA Company Overview 89
5.22.1 Biocorp Production SA Pipeline Products & Ongoing Clinical Trials Overview 89
5.23 BioCorRx Inc Company Overview 90
5.23.1 BioCorRx Inc Pipeline Products & Ongoing Clinical Trials Overview 90
5.24 Biorchestra Co Ltd Company Overview 94
5.24.1 Biorchestra Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 94
5.25 BioRestorative Therapies Inc Company Overview 95
5.25.1 BioRestorative Therapies Inc Pipeline Products & Ongoing Clinical Trials Overview 95
5.26 Bioxis Pharmaceuticals Company Overview 96
5.26.1 Bioxis Pharmaceuticals Pipeline Products & Ongoing Clinical Trials Overview 96
5.27 Brigham and Women’s Hospital Company Overview 97
5.27.1 Brigham and Women’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 97
5.28 Burke Pharmaceuticals LLC Company Overview 98
5.28.1 Burke Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview 98
5.29 Calla Health Foundation Company Overview 99
5.29.1 Calla Health Foundation Pipeline Products & Ongoing Clinical Trials Overview 99
5.30 Callisyn Biomedical Inc Company Overview 100
5.30.1 Callisyn Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 100
5.31 Cambridge Consultants Ltd Company Overview 101
5.31.1 Cambridge Consultants Ltd Pipeline Products & Ongoing Clinical Trials Overview 101
5.32 Camurus AB Company Overview 102
5.32.1 Camurus AB Pipeline Products & Ongoing Clinical Trials Overview 102
5.33 Case Western Reserve University Company Overview 106
5.33.1 Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview 106
5.34 Cincinnati Children’s Hospital Medical Center Company Overview 107
5.34.1 Cincinnati Children’s Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview 107
5.35 Clearside BioMedical Inc Company Overview 108
5.35.1 Clearside BioMedical Inc Pipeline Products & Ongoing Clinical Trials Overview 108
5.36 Coherus BioSciences Inc Company Overview 112
5.36.1 Coherus BioSciences Inc Pipeline Products & Ongoing Clinical Trials Overview 112
5.37 Copernicus Sp zoo Company Overview 113
5.37.1 Copernicus Sp zoo Pipeline Products & Ongoing Clinical Trials Overview 113
5.38 CrossCoat Medical LLC Company Overview 117
5.38.1 CrossCoat Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 117
5.39 Crossject SA Company Overview 118
5.39.1 Crossject SA Pipeline Products & Ongoing Clinical Trials Overview 118
5.40 DALI Medical Devices Ltd. Company Overview 119
5.40.1 DALI Medical Devices Ltd. Pipeline Products & Ongoing Clinical Trials Overview 119
5.41 DelSite, Inc. (Inactive) Company Overview 123
5.41.1 DelSite, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 123
5.42 Department of Biomedical Engineering Columbia University Company Overview 124
5.42.1 Department of Biomedical Engineering Columbia University Pipeline Products & Ongoing Clinical Trials Overview 124
5.43 Difinity Solutions Company Overview 125
5.43.1 Difinity Solutions Pipeline Products & Ongoing Clinical Trials Overview 125
5.44 Drexel University Company Overview 126
5.44.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview 126
5.45 Duoject Medical Systems Inc Company Overview 127
5.45.1 Duoject Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 127
5.46 Ebenroth BV Company Overview 128
5.46.1 Ebenroth BV Pipeline Products & Ongoing Clinical Trials Overview 128
5.47 Ecole Polytechnique Federale de Lausanne Company Overview 129
5.47.1 Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview 129
5.48 Elcam Medical Company Overview 130
5.48.1 Elcam Medical Pipeline Products & Ongoing Clinical Trials Overview 130
5.49 EmboMedics Inc Company Overview 136
5.49.1 EmboMedics Inc Pipeline Products & Ongoing Clinical Trials Overview 136
5.50 Embryyo Technologies Pvt Ltd Company Overview 137
5.50.1 Embryyo Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 137
5.51 Emergent BioSolutions Inc Company Overview 138
5.51.1 Emergent BioSolutions Inc Pipeline Products & Ongoing Clinical Trials Overview 138
5.52 EP Global Communications Inc (Inactive) Company Overview 143
5.52.1 EP Global Communications Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 143
5.53 Eveon SAS Company Overview 144
5.53.1 Eveon SAS Pipeline Products & Ongoing Clinical Trials Overview 144
5.54 EyePoint Pharmaceuticals Inc Company Overview 147
5.54.1 EyePoint Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 147
5.55 FHC Inc Company Overview 152
5.55.1 FHC Inc Pipeline Products & Ongoing Clinical Trials Overview 152
5.56 FluGen Inc Company Overview 153
5.56.1 FluGen Inc Pipeline Products & Ongoing Clinical Trials Overview 153
5.57 Fresenius SE & Co KGaA Company Overview 154
5.57.1 Fresenius SE & Co KGaA Pipeline Products & Ongoing Clinical Trials Overview 154
5.58 GeneSYS-ID Inc Company Overview 155
5.58.1 GeneSYS-ID Inc Pipeline Products & Ongoing Clinical Trials Overview 155
5.59 Georgia Institute of Technology Company Overview 156
5.59.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 156
5.60 Ghent University Company Overview 158
5.60.1 Ghent University Pipeline Products & Ongoing Clinical Trials Overview 158
5.61 Globe Medical Tech Inc (Inactive) Company Overview 159
5.61.1 Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 159
5.62 Hillmed Inc Company Overview 161
5.62.1 Hillmed Inc Pipeline Products & Ongoing Clinical Trials Overview 161
5.63 Immunovant Inc Company Overview 164
5.63.1 Immunovant Inc Pipeline Products & Ongoing Clinical Trials Overview 164
5.64 Impulse Biomedical Company Overview 165
5.64.1 Impulse Biomedical Pipeline Products & Ongoing Clinical Trials Overview 165
5.65 Inovio Pharmaceuticals Inc Company Overview 166
5.65.1 Inovio Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 166
5.66 Inventage Lab Inc Company Overview 169
5.66.1 Inventage Lab Inc Pipeline Products & Ongoing Clinical Trials Overview 169
5.67 InVivo Therapeutics Corp Company Overview 172
5.67.1 InVivo Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview 172
5.68 JCR Pharmaceuticals Co Ltd Company Overview 173
5.68.1 JCR Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 173
5.69 komarik Company Overview 174
5.69.1 komarik Pipeline Products & Ongoing Clinical Trials Overview 174
5.70 LG Chem Ltd Company Overview 175
5.70.1 LG Chem Ltd Pipeline Products & Ongoing Clinical Trials Overview 175
5.71 Liposphere Ltd Company Overview 176
5.71.1 Liposphere Ltd Pipeline Products & Ongoing Clinical Trials Overview 176
5.72 LyoGo Company Overview 179
5.72.1 LyoGo Pipeline Products & Ongoing Clinical Trials Overview 179
5.73 Mallinckrodt Plc Company Overview 180
5.73.1 Mallinckrodt Plc Pipeline Products & Ongoing Clinical Trials Overview 180
5.74 Medovate Ltd Company Overview 181
5.74.1 Medovate Ltd Pipeline Products & Ongoing Clinical Trials Overview 181
5.75 Mercator MedSystems Inc Company Overview 184
5.75.1 Mercator MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview 184
5.76 Mertiva AB Company Overview 190
5.76.1 Mertiva AB Pipeline Products & Ongoing Clinical Trials Overview 190
5.77 Midas Pharma GmbH Company Overview 191
5.77.1 Midas Pharma GmbH Pipeline Products & Ongoing Clinical Trials Overview 191
5.78 Milestone Scientific Inc Company Overview 192
5.78.1 Milestone Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 192
5.79 Monash University Company Overview 198
5.79.1 Monash University Pipeline Products & Ongoing Clinical Trials Overview 198
5.80 Morimoto Pharma Co Ltd Company Overview 199
5.80.1 Morimoto Pharma Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 199
5.81 NanoSyrinx Ltd Company Overview 200
5.81.1 NanoSyrinx Ltd Pipeline Products & Ongoing Clinical Trials Overview 200
5.82 National University of Ireland Galway Company Overview 201
5.82.1 National University of Ireland Galway Pipeline Products & Ongoing Clinical Trials Overview 201
5.83 Nemera La Verpilliere Company Overview 202
5.83.1 Nemera La Verpilliere Pipeline Products & Ongoing Clinical Trials Overview 202
5.84 Nipro Corp Company Overview 204
5.84.1 Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 204
5.85 Nota Laboratories LLC Company Overview 205
5.85.1 Nota Laboratories LLC Pipeline Products & Ongoing Clinical Trials Overview 205
5.86 Novo Nordisk AS Company Overview 206
5.86.1 Novo Nordisk AS Pipeline Products & Ongoing Clinical Trials Overview 206
5.87 Novosanis NV Company Overview 211
5.87.1 Novosanis NV Pipeline Products & Ongoing Clinical Trials Overview 211
5.88 NuvOx Pharma LLC Company Overview 212
5.88.1 NuvOx Pharma LLC Pipeline Products & Ongoing Clinical Trials Overview 212
5.89 Ocular Therapeutix Inc Company Overview 213
5.89.1 Ocular Therapeutix Inc Pipeline Products & Ongoing Clinical Trials Overview 213
5.90 Old Dominion University Company Overview 217
5.90.1 Old Dominion University Pipeline Products & Ongoing Clinical Trials Overview 217
5.91 Osteo Pharma BV Company Overview 218
5.91.1 Osteo Pharma BV Pipeline Products & Ongoing Clinical Trials Overview 218
5.92 Oval Medical Technologies Ltd Company Overview 219
5.92.1 Oval Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 219
5.93 Owen Mumford Ltd Company Overview 221
5.93.1 Owen Mumford Ltd Pipeline Products & Ongoing Clinical Trials Overview 221
5.94 Palatin Technologies Inc Company Overview 223
5.94.1 Palatin Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 223
5.95 Palette Life Sciences AB Company Overview 224
5.95.1 Palette Life Sciences AB Pipeline Products & Ongoing Clinical Trials Overview 224
5.96 Particle Therapeutics Ltd Company Overview 225
5.96.1 Particle Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview 225
5.97 Pharmosa Biopharm Inc Company Overview 226
5.97.1 Pharmosa Biopharm Inc Pipeline Products & Ongoing Clinical Trials Overview 226
5.98 PHC Holdings Corp Company Overview 227
5.98.1 PHC Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 227
5.99 Portal Instruments Inc Company Overview 228
5.99.1 Portal Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview 228
5.100 Prohibix LLC Company Overview 229
5.100.1 Prohibix LLC Pipeline Products & Ongoing Clinical Trials Overview 229
5.101 QuiO Technologies LLC Company Overview 230
5.101.1 QuiO Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 230
5.102 Rebel Medicine Corp Company Overview 232
5.102.1 Rebel Medicine Corp Pipeline Products & Ongoing Clinical Trials Overview 232
5.103 Recon Therapeutics, LLC Company Overview 233
5.103.1 Recon Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 233
5.104 Regeneron Pharmaceuticals Inc Company Overview 234
5.104.1 Regeneron Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 234
5.105 Renovos Biologics Ltd Company Overview 240
5.105.1 Renovos Biologics Ltd Pipeline Products & Ongoing Clinical Trials Overview 240
5.106 RepliCel Life Sciences Inc Company Overview 241
5.106.1 RepliCel Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 241
5.107 Rescitech Vision Pvt Ltd Company Overview 242
5.107.1 Rescitech Vision Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 242
5.108 RetinaPharma Technologies Inc Company Overview 243
5.108.1 RetinaPharma Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 243
5.109 Sapporo Medical University School of Medicine Company Overview 244
5.109.1 Sapporo Medical University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview 244
5.110 Schott AG Company Overview 245
5.110.1 Schott AG Pipeline Products & Ongoing Clinical Trials Overview 245
5.111 Singapore Eye Research Institute Company Overview 246
5.111.1 Singapore Eye Research Institute Pipeline Products & Ongoing Clinical Trials Overview 246
5.112 Sorrento Therapeutics Inc Company Overview 247
5.112.1 Sorrento Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 247
5.113 Southern Medical University Company Overview 248
5.113.1 Southern Medical University Pipeline Products & Ongoing Clinical Trials Overview 248
5.114 Spinal Restoration Inc (Inactive) Company Overview 249
5.114.1 Spinal Restoration Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 249
5.115 Stevanato Group SpA Company Overview 250
5.115.1 Stevanato Group SpA Pipeline Products & Ongoing Clinical Trials Overview 250
5.116 Subcuject ApS Company Overview 251
5.116.1 Subcuject ApS Pipeline Products & Ongoing Clinical Trials Overview 251
5.117 Sunshine Guojian Pharmaceutical Shanghai Co Ltd Company Overview 252
5.117.1 Sunshine Guojian Pharmaceutical Shanghai Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 252
5.118 Takeda Pharmaceutical Co Ltd Company Overview 253
5.118.1 Takeda Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 253
5.119 TCB medical devices Company Overview 255
5.119.1 TCB medical devices Pipeline Products & Ongoing Clinical Trials Overview 255
5.120 Tempest Therapeutics Inc Company Overview 256
5.120.1 Tempest Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 256
5.121 Terumo Corp Company Overview 257
5.121.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 257
5.122 Teva Pharmaceutical Industries Ltd Company Overview 259
5.122.1 Teva Pharmaceutical Industries Ltd Pipeline Products & Ongoing Clinical Trials Overview 259
5.123 Teva Pharmaceuticals USA Inc Company Overview 260
5.123.1 Teva Pharmaceuticals USA Inc Pipeline Products & Ongoing Clinical Trials Overview 260
5.124 TheraKine Inc (Inactive) Company Overview 261
5.124.1 TheraKine Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 261
5.125 Twin Star Medical Inc Company Overview 263
5.125.1 Twin Star Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 263
5.126 Unilife Corporation Company Overview 264
5.126.1 Unilife Corporation Pipeline Products & Ongoing Clinical Trials Overview 264
5.127 University College London Company Overview 269
5.127.1 University College London Pipeline Products & Ongoing Clinical Trials Overview 269
5.128 University of Calgary Company Overview 270
5.128.1 University of Calgary Pipeline Products & Ongoing Clinical Trials Overview 270
5.129 University of California San Diego Company Overview 271
5.129.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 271
5.130 University of California San Francisco Company Overview 273
5.130.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 273
5.131 University of Delaware Company Overview 274
5.131.1 University of Delaware Pipeline Products & Ongoing Clinical Trials Overview 274
5.132 University of Dundee Company Overview 275
5.132.1 University of Dundee Pipeline Products & Ongoing Clinical Trials Overview 275
5.133 University of Florida Company Overview 276
5.133.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 276
5.134 University of Michigan Company Overview 278
5.134.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 278
5.135 University of New Mexico Company Overview 279
5.135.1 University of New Mexico Pipeline Products & Ongoing Clinical Trials Overview 279
5.136 University of Saskatchewan Company Overview 280
5.136.1 University of Saskatchewan Pipeline Products & Ongoing Clinical Trials Overview 280
5.137 University of South Florida Company Overview 281
5.137.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 281
5.138 University of Texas at Austin Company Overview 282
5.138.1 University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview 282
5.139 University of Texas at San Antonio Company Overview 283
5.139.1 University of Texas at San Antonio Pipeline Products & Ongoing Clinical Trials Overview 283
5.140 Vanderbilt University Company Overview 284
5.140.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 284
5.141 West Pharmaceutical Services Inc Company Overview 285
5.141.1 West Pharmaceutical Services Inc Pipeline Products & Ongoing Clinical Trials Overview 285
5.142 Windgap Medical Inc Company Overview 286
5.142.1 Windgap Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 286
5.143 Xeris Biopharma Holdings Inc Company Overview 291
5.143.1 Xeris Biopharma Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 291
5.144 Ypsomed Holding AG Company Overview 292
5.144.1 Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview 292
5.145 ZebraSci Inc Company Overview 293
5.145.1 ZebraSci Inc Pipeline Products & Ongoing Clinical Trials Overview 293
5.146 Zosano Pharma Corp Company Overview 295
5.146.1 Zosano Pharma Corp Pipeline Products & Ongoing Clinical Trials Overview 295
6 Injectable Drug Delivery- Recent Developments 297
6.1 Jul 18, 2022: Emergent BioSolutions Announces Appointment of Sujata Dayal to Board of Directors 297
6.2 Jul 18, 2022: Emergent BioSolutions to Release Second Quarter 2022 Financial Results and Conduct Conference Call on August 1, 2022 297
6.3 Jul 18, 2022: EyePoint reports preliminary Q2 net product revenue $11.3M 297
6.4 Jul 11, 2022: EyePoint Pharmaceuticals to Host Investor Day on July 18, 2022 299
6.5 Jul 06, 2022: Biogen to Report Second Quarter 2022 Financial Results July 20, 2022 299
6.6 Jul 05, 2022: Mylan Pharmaceuticals a Viatris Company, issues voluntary nationwide recall of one batch of Insulin Glargine (Insulin glargine-yfgn) injection pens, 100 units/mL (U-100), due to the potential of missing labels on some pens 299
6.7 Jul 01, 2022: Viatris to Release Second Quarter 2022 Financial Results on August 8, 2022 300
6.8 Jun 30, 2022: Annual General Meeting of Ypsomed elects new Chairman 300
6.9 Jun 28, 2022: Eevia Healtheceives a 230 KSEK/21 KEUR starting sales order for a new Lingonberry product to a new customer 301
6.10 Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director 302
6.11 Jun 24, 2022: Eton Pharmaceuticals announces sale of hospital products 302
6.12 Jun 24, 2022: Pfizer Invites Public to View and Listen to Webcast of July 28 Conference Call with Analysts 304
6.13 Jun 22, 2022: Biora Therapeutics announces presentation at the 2022 Parenteral Drug Association Universe of Pre-Filled Syringes and Injection Devices Conference 304
6.14 Jun 10, 2022: Midatech Pharma to appoint Dr. Stephen Parker as non-executive Chairman of the Board 304
6.15 Jun 09, 2022: Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference 305
6.16 Jun 08, 2022: Biogen Withdrawal from the Jefferies Healthcare Conference 305
6.17 Jun 07, 2022: BD Names Simon Campion as Medical Segment President 305
6.18 Jun 07, 2022: Albireo to Present New Data at the 54th Annual Meeting of ESPGHAN 305
6.19 Jun 03, 2022: United Therapeutics to Present at the Jefferies Healthcare Conference 307
6.20 Jun 02, 2022: BD to Present at Goldman Sachs 43rd Annual Global Healthcare Conference 307
6.21 Jun 02, 2022: Emergent BioSolutions to Participate in Investor Conferences 307
6.22 May 30, 2022: Jubilant HollisterStier LLC enters into cooperative agreement of $149.6 Mn with US Government to expand critical vaccine manufacturing capacity 308
6.23 May 30, 2022: Top Clean Injection invests in Teklyx software 308
6.24 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results 308
6.25 May 26, 2022: Adamis Appoints Vickie Reed to Board of Directors 308
6.26 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase 309
6.27 May 25, 2022: Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference 309
6.28 May 24, 2022: Midatech Pharma Announces Notice of Annual General Meeting 309
6.29 May 23, 2022: Milestone Scientific Announces the Appointment of Retail Industry Veteran Ms. Benedetta Casamento to its Board of Directors 310
6.30 May 20, 2022: Viatris to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference 310
6.31 May 19, 2022: Dr Reddy’s Profit may rise 20-24% on 12% growth in revenue 310
6.32 May 18, 2022: Dr. Brandee Pappalardo Joins Fresenius Kabi as Chief Medical Officer for North America 310
6.33 May 16, 2022: Adamis Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update 311
6.34 May 14, 2022: Emergent BioSolutions to Participate in Investor Conferences 312
6.35 May 12, 2022: Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 26, 2022 at 9:00am EDT 313
6.36 May 12, 2022: Eton Pharmaceuticals Reports First Quarter 2022 Financial Results 313
6.37 May 11, 2022: Babson, BD expand strategic partnership to advance diagnostic blood collection in new care settings 315
6.38 May 10, 2022: PharmaJet Announces Addition of Darin Zehrung as Chief Business Development Officer 316
6.39 May 09, 2022: Viatris Reports Strong First-Quarter 2022 Results 317
6.40 May 09, 2022: Delcath Announces Poster Presentation at the 2022 ASCO Annual Meeting 318
6.41 May 09, 2022: Adamis Pharmaceuticals Schedules First Quarter 2022 Financial Results Conference Call and Business Update 319
6.42 May 05, 2022: Virpax Pharmaceuticals enters into CRADA with the U.S. Army Institute of Surgical Research 319
6.43 May 03, 2022: Biogen Reports First Quarter 2022 Results 320
6.44 May 03, 2022: Sanofi: Annual General Meeting of May 3, 2022 321
6.45 May 03, 2022: Eton Pharmaceuticals to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022 321
6.46 May 03, 2022: Pfizer Reports First quarter 2022 Results 321
6.47 Apr 29, 2022: BD to Present at the BofA Securities 2022 Healthcare Conference 326
6.48 Apr 28, 2022: Emergent BioSolutions Reports Financial Results For First Quarter 2022 326
6.49 Apr 27, 2022: United Therapeutics Corporation to Report First Quarter 2022 Financial Results Before the Market Opens on Wednesday, May 4, 2022 330
6.50 Apr 27, 2022: Zentalis Pharmaceuticals Announces $25 Million Equity Investment from Pfizer 330
6.51 Apr 27, 2022: BioMarin Announces Record Revenues in First Quarter 2022 331
6.52 Apr 26, 2022: Midatech Pharma Results for the Year Ended 31 December 2021 333
6.53 Apr 22, 2022: Merck Notice of Annual General Meeting Approval of all Agenda Items 334
6.54 Apr 19, 2022: Pfizer Invites Shareholders to Attend Virtual-Only 2022 Annual Meeting of Shareholders on April 28 334
6.55 Apr 13, 2022: PharmaJet launches new interactive website 335
6.56 Apr 11, 2022: Eton Pharmaceuticals Appoints James Gruber as Chief Financial Officer 335
6.57 Apr 08, 2022: Emergent BioSolutions to Release First Quarter 2022 Financial Results and Conduct Conference Call on April 28, 2022 336
6.58 Apr 08, 2022: Viatris to Release First Quarter 2022 Financial Results on May 9, 2022 336
6.59 Apr 04, 2022: Dr. Reddy’s appoints Anish Agarwal as head of analytics 337
6.60 Mar 31, 2022: Adamis Pharmaceuticals Reports Full Year 2021 Financial Results and Provides Corporate Update 337
6.61 Mar 29, 2022: ClearPoint Neuro to Present at the B. Riley Securities Disruptive Biotech Enabling Technologies Mini Conference 339
6.62 Mar 24, 2022: Adamis Pharmaceuticals Schedules Fourth Quarter and Full Year 2021 Financial Results Conference Call and Business Update 339
6.63 Mar 24, 2022: Novo Nordisk Announces Resolutions from the Annual General Meeting 339
6.64 Mar 24, 2022: Resolutions from the Annual General Meeting of Novo Nordisk 340
6.65 Mar 18, 2022: Catalent to Present at the KeyBanc Life Sciences & MedTech Investor Forum 342
6.66 Mar 17, 2022: Dr. Reddy’s Laboratories announced appointment of company secretary and compliance officer 342
6.67 Mar 16, 2022: Eton Pharmaceuticals Reports Fourth Quarter 2021 Financial Results 342
6.68 Mar 10, 2022: Watson Pharmaceutical Announces Postponing the Replacement and Election of Independent Directors 344
6.69 Mar 08, 2022: United Therapeutics to Present at the Oppenheimer 32nd Annual Healthcare Conference 344
6.70 Mar 03, 2022: Lung metastases, cytoreductive nephrectomy and favourable risk group associated with a higher probability of response to first-line combination therapy in MRCC 344
6.71 Mar 01, 2022: PharmaJet Vaccine Delivery Featured at Sabin Vaccine Institute Conference 345
6.72 Mar 01, 2022: Viatris to Participate in Upcoming Investor Conferences 346
6.73 Feb 28, 2022: Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference 346
6.74 Feb 24, 2022: United Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results 346
6.75 Feb 24, 2022: BD to Present at the Cowen 42nd Annual Health Care Conference 351
6.76 Feb 23, 2022: embecta to Host Virtual Investor Event Ahead of Planned Spinoff from BD 352
6.77 Feb 23, 2022: Ypsomed focuses on growth and strengthens its business units 352
6.78 Feb 23, 2022: Bd Appoints Shana Neal as Chief People Officer 353
6.79 Feb 21, 2022: United Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results Before the Market Opens on Thursday, February 24, 2022 353
6.80 Feb 21, 2022: Notice for the Annual General Meeting of Novo Nordisk 354
6.81 Feb 16, 2022: Unlearn signs multi-year collaboration with Merck KGaA, Darmstadt, Germany to Accelerate Immunology Trials using Twintelligent RCTs 354
6.82 Feb 15, 2022: PharmaJet partner Technovalia announces interim results of needle-free COVID-19 vaccine trial 355
6.83 Feb 15, 2022: News outlets highlight Virpax Pharmaceuticals and its potential solutions for the opioid crisis and COVID-19 355
6.84 Feb 09, 2022: Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference 356
6.85 Feb 04, 2022: Viatris to Host Virtual Investor Event and Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2022 356
6.86 Feb 02, 2022: Halozyme Appoints New Chief Financial Officer 356
6.87 Feb 01, 2022: Pfizer Announces New Chief Development Officer 357
6.88 Feb 01, 2022: Akhil Ravi appointed CEO of Aurigene Pharmaceutical Services 357
6.89 Jan 18, 2022: Milestone Scientific CEO to Participate in Fireside Chat Hosted by Maxim Group and M-Vest on January 20th 358
6.90 Jan 09, 2022: Emergent BioSolutions Announces 2022 Financial Guidance, Provides Preliminary 2021 Results 358
6.91 Jan 06, 2022: BD Announces Change to Virtual 2022 Annual Meeting of Shareholders 360
6.92 Jan 05, 2022: Catalent Announces Plan for Alessandro Maselli to Become New CEO Effective July 1, 2022 361
6.93 Jan 05, 2022: BD to announce financial results for its first quarter of fiscal year 2022 361
6.94 Jan 04, 2022: Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference 361
6.95 Jan 03, 2022: Emergent BioSolutions to Participate in Investor Conferences 362
6.96 Dec 30, 2021: United Therapeutics to Webcast Executive Fireside Chat Conversation With J.P. Morgan Analyst 362
6.97 Dec 30, 2021: Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference 362
6.98 Dec 21, 2021: BD Announces Board of Directors for embecta, the Planned Spinoff of its Diabetes Care Business 363
6.99 Dec 17, 2021: Iktos and The University of Dundee, Drug Discovery Unit (DDU) announce a collaboration to use AI for drug design and retrosyntheis 365
6.100 Dec 02, 2021: Albireo Expands Leadership with Constantine Chinoporos as Chief Business Officer 365
6.101 Nov 24, 2021: Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference 366
6.102 Nov 22, 2021: Adamis Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Corporate Update 366
6.103 Nov 18, 2021: Viatris to Participate in Evercore ISI 4th Annual HealthCONx Conference 368
6.104 Nov 16, 2021: Nemera to build state-of-the-art manufacturing facility in Poland to serve more customers and patients 369
6.105 Nov 15, 2021: Milestone Scientific Reports 69% Increase in Revenue for Third Quarter of 2021 369
6.106 Nov 15, 2021: Eton Pharmaceuticals Reports Third Quarter Financial Results 370
6.107 Nov 11, 2021: Viatris donates $1 million as founding champion to new orleans-based SBP’s “Got Your Back” fund in Support of Housing Solutions for Veterans in Disaster-Impacted Communities 372
6.108 Nov 11, 2021: Milestone Scientific Schedules Third Quarter 2021 Business Update Conference Call 373
6.109 Nov 11, 2021: Polymer Factory Sweden AB extends quality agreement with Merck KGaA 373
6.110 Nov 10, 2021: Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference 374
6.111 Nov 09, 2021: Delcath Systems Announces Third Quarter 2021 Results 374
6.112 Nov 08, 2021: Viatris Reports Strong Third Quarter Results, Raises 2021 Financial Guidance and Announces Virtual Investor Event on January 7, 2022 376
6.113 Nov 04, 2021: Antares Pharma Reports Third Quarter 2021 Financial and Operating Results 378
6.114 Nov 04, 2021: Ypsomed is growing and expects a further increase 380
6.115 Nov 03, 2021: Novo Nordisk’s net profit increased by 12% in the first nine months of 2021 381
6.116 Nov 03, 2021: United Therapeutics Reports Third Quarter 2021 Financial Results 381
6.117 Nov 03, 2021: EyePoint Pharmaceuticals Reports Third Quarter 2021 Financial Results and Highlights Recent Corporate Developments 382
6.118 Nov 02, 2021: Halozyme Reports Third Quarter 2021 Results 383
6.119 Nov 01, 2021: United Therapeutics To Present At The Credit Suisse 30th Annual Healthcare Conference 385
6.120 Nov 01, 2021: United Therapeutics Corporation To Present At The Credit Suisse 30th Annual Healthcare Conference 386
6.121 Oct 29, 2021: Dr. Reddy’s announces Q2 & H1 FY22 Financial Results 386
6.122 Oct 28, 2021: Sanofi announces strong Q3 performance drives guidance upgrade to around 14% business EPS growth at CER 386
6.123 Oct 26, 2021: BD to Host Investor Day on November 12 396
6.124 Oct 22, 2021: Physiomics: Contract awards 397
6.125 Oct 18, 2021: Emergent BioSolutions to Release Third Quarter 2021 Financial Results and Conduct a Conference Call on November 4, 2021 397
6.126 Oct 13, 2021: Viatris to Release Third Quarter 2021 Financial Results on Nov. 8, 2021 397
6.127 Oct 04, 2021: Adamis Announces Appointment of Meera Desai, Ph.D., to Board of Directors 397
6.128 Sep 22, 2021: BD completes study investigating performance of glass prefillable syringes (PFS) in deep cold storage 398
6.129 Sep 20, 2021: Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference 398
6.130 Sep 15, 2021: Biogen Announces Agenda for Virtual Investor Day R&D Day on September 21, 2021 399
6.131 Sep 08, 2021: Antares Pharma to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference 400
6.132 Aug 26, 2021: Pfizer Announces New Chief Business Innovation Officer 400
6.133 Aug 19, 2021: Dan Berish Joins Precision Medical Products as New President of Acute Care Division 400
6.134 Aug 17, 2021: Midatech Pharma Announces Change of registered office 401
6.135 Aug 11, 2021: Raymed Labs – Unaudited Financial Results For Quarter Ended 30Th June 2021 401
6.136 Aug 11, 2021: Raymed Labs Announces resignation of Mrs. Nisha Goyal from the post of the CFO 401
6.137 Aug 10, 2021: Delcath Systems Announces Second Quarter 2021 Results 402
6.138 Aug 08, 2021: Raymed Labs Announces Appointment of Additional Director 403
6.139 Aug 05, 2021: Antares Pharma Reports Second Quarter 2021 Financial and Operating Results 403
6.140 Aug 05, 2021: Fuji Pharma Announces Financial Results for the 3rd Quarter of the Fiscal Year Ending September 2021 405
6.141 Aug 05, 2021: Albireo Reports Q2 Financial Results and Business Update 406
6.142 Aug 05, 2021: Berry Global announces major healthcare investment in India 407
6.143 Aug 04, 2021: United Therapeutics Reports Second Quarter 2021 Financial Results 408
6.144 Aug 04, 2021: B. Braun Medical announced to recall the product Horizon pump blood set 408
6.145 Aug 03, 2021: United Therapeutics To Present At The 2021 Wedbush PacGrow Healthcare Virtual Conference 409
6.146 Aug 03, 2021: Eton Pharmaceuticals to Report Second Quarter 2021 Financial Results on Monday, August 16, 2021 409
6.147 Jul 30, 2021: Halozyme to Participate in Canaccord Genuity 41st Annual Growth Conference 410
6.148 Jul 30, 2021: Virpax Pharmaceuticals Strengthens Board of Directors with the Appointment of Gerald W. Bruce and Michael F. Dubin, CPA to its Board 410
6.149 Jul 29, 2021: Sanofi announces half-year financial report for period ending June 30, 2021 410
6.150 Jul 29, 2021: West Announces Second-Quarter 2021 Results 410
6.151 Jul 29, 2021: BD to Present at UBS Genomics
2.0 and MedTech Innovations Summit 413
6.152 Jul 29, 2021: Emergent BioSolutions Reports Financial Results For Second Quarter 2021 413
6.153 Jul 28, 2021: United Therapeutics To Report Second Quarter 2021 Financial Results Before The Market Opens On Wednesday, August 4, 2021 417
6.154 Jul 28, 2021: Teva Reports Second Quarter 2021 Financial Results 417
6.155 Jul 28, 2021: EyePoint Pharmaceuticals to Report Second Quarter 2021 Financial Results on August 4, 2021 419
6.156 Jul 28, 2021: Antares Pharma to Report Second Quarter 2021 Financial and Operating Results 420
6.157 Jul 28, 2021: Delcath Systems Schedules Conference Call to Report 2021 Second Quarter Financial Results 420
6.158 Jul 28, 2021: Pfizer Announces Unaudited Financial Results For The Quarter Ended June 30, 2021. 420
6.159 Jul 27, 2021: Dr. Reddy’s announce Q1 FY22 Financial Results 421
6.160 Jul 27, 2021: Halozyme To Host Second Quarter 2021 Financial Results Webcast and Conference Call 421
6.161 Jul 27, 2021: Dr Reddys Laboratories Unaudited Financial Results For The Quarter Ended June 30, 2021 421
7 Appendix 423
7.1 Methodology 423
7.2 About GlobalData 426
7.3 Contact Us 426
7.4 Disclaimer 426
